维普中文期刊产品整合服务
47篇 您的检索式:作者名="Quinn DI"
    题名 作者 年代 出处 被引量
1Human immunodeficiency virus-related primary central nervous system lymphoma: factors influencing survival in 111 patients显示文摘BACKGROUND: The current study evaluated factors influencing survival in patients diagnosed with human immunodeficiency virus (HIV)-related primary central nervous system lymphoma (PCNSL), with a focus on the effects of therapeutic radiotherapy (RT) and highly active antiretroviral therapy (HAART). METHODS: A retrospective chart review of patients with a diagnosis of HIV-related PCNSL at one of five university hospitals between 1987 and 1998 was performed. Clinical details including antiretroviral agent use, brain imaging scan results, RT use, and survival outcomes were recorded. RESULTS: One hundred eleven patients with HIV-related PCNSL were identified. The annual incidence decreased significantly between 1992 and 1995 and between 1996 and 1998 (P=0.04).Newell ME Hoy JF Cooper SG DeGraaff B Grulich AE Bryant M Millar JL Brew BJ Quinn DI 2004中国神经肿瘤杂志2004,2,2:4
2Molecular marker of prostate cancer outcome显示文摘Quinn DI Henshall SM Sutherland RL 2005Cancer2005,41,6:1
3Cytokine therapy : a standard of care for me-tastatic renal cell carcinoma显示文摘Hutson TE Quinn DI 2005Clin Genitourin Cancer2005,4,3:1
4Phase Ⅱ study of eribulin (E7389) in patients (pts) with advanced urothelial cancer ( UC ) -final report: a California Cancer consortium-led NCI/CTEP-sponsored trial 显示文摘Quinn DI Aparicio A Tsao-Wei DD 2010J Clin Oncol2010,,:1
5Granulosa cell tumors erpress erbB4 and are sensitive to the cytotoxic action of heregulin- beta2/PE40 显示文摘Furger C Fiddes RJ Quinn DI 1998Cancer Res1998,58,9:1
6Phase I trial of anti - sense oligonucleotide vascular endothelial growth factor (VEGFAS, Veglin) in patients with relapsed and refractory malignancies 显示文摘Levine AM Quinn DI Gorospe G 2004Am Soc Clin Oneol2004,22,14:1
7Sequencing therapy in advanced prostate cancer: focus on sipuleucel-T 显示文摘Quinn DI Vaishampayan U Higano CS 2014Expert Rev Anticancer Ther2014,14,1:1
8Docetaxel and atrasentan versus doeetaxel and placebo for men with advanced castration-resistant prostate cancer(SWOG S0421): a random- ised phase 3 trial显示文摘QUINN DI TANGEN CM HUSSAIN M 2013Lancet Oncol2013,14,9:1
9Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer(SWOG S0421):a randomised phase 3 trial显示文摘QUINN DI TANGEN CM HUSSAIN M 2013Lancet Oncol2013,14,9:1
10The cyclin-dependent kinase inhibitor UCN-01 plus cisplatin in advanced solid tumors:a California cancer consortium phase Ⅰ pharmacokinetic and molecular correlative trial显示文摘Lara PN Jr Quinn DI Margolin K 2005Clin Cancer Res2005,,9:1
11The AKT inhibitor perifosine in biochemically recurrent prostate cancer:a phase II California/Pittsburgh cancer consortium triM显示文摘Chee KG Longmate J Quinn DI 2007Clin Genitourin Cancer2007,5,7:1
12Circulating tumor cellcounts are prognostic of overall survival in SWOG S0421 : a phaseIII trial of docetaxel with or without atrasentan for metastaticcastration-resistant prostate cancer 显示文摘Goldkom A Ely B Quinn DI 2014J Clin Oncol2014,32,11:1
13Resistance to imipenem in pseudomonas aeruginosa:clinical experience and bio chemical mechanisms显示文摘Quinn J P Studemeister A E Di Vencenzo C A 1998Rev Infect Dis1998,10,:1
14Zinc-α2-gly-coprotein expression as a predictor of metastatic prostate cancer following radical prostatectomy显示文摘Henshall SM Horvath LG Quinn DI 0,,19:1
15The AKT inhibi- tor perifosine in biochemically recurrent prostate cancer: a phase 1I California/Pittsburgh cancer consortium trial 显示文摘Chee KG Longmate J Quinn DI 2007Clin Genitourin Cancer2007,5,7:1
16Molecular markers of prostate cancer outcome 显示文摘Quinn DI Henshall SM Sutherland RL 2005Cancer2005,41,6:1
17Primary treatment of nasolacrimal duct obstruction with probing in children younger than 4 years显示文摘Pediatric Eye Disease Investigator Group Repka MX Chandler DL Beck RW Crouch ER 3rd Donahue S Holmes JM Lee K Melia M Quinn GE Sala NA Schloff S Silbert DI Wallace DK 0,,03:1
18Prognostic significance of p53 nuclear accumulation in localized prostate cancer treated with radical prostatectomy显示文摘Quinn DI Henshall SM Head DR 2000Cancer Res2000,60,6:1
19Current and recent clinical trials for perioperative systemic therapy for muscle invasive bladder cancer: a systematic review 显示文摘Vashistha V Quinn DI Dorff TB 2014BMC Cancer2014,14,:1
20Sequencing thera- py in advanced prostate cancer: focus on sipuleucel -T 显示文摘Quinn DI Vaishampayan U Higano CS 2014Ex- pert Rev Anticancer Ther2014,14,1:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费